| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 744 | 2021 |
| Hijacking of the AP-1 signaling pathway during development of ATL H Gazon, B Barbeau, JM Mesnard, JM Peloponese Jr Frontiers in microbiology 8, 2686, 2018 | 243 | 2018 |
| Recent advances in BLV research PY Barez, A De Brogniez, A Carpentier, H Gazon, N Gillet, G Gutiérrez, ... Viruses 7 (11), 6080-6088, 2015 | 117 | 2015 |
| Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3′ long terminal repeat H Gazon, I Lemasson, N Polakowski, R Césaire, M Matsuoka, B Barbeau, ... Journal of virology 86 (17), 9070-9078, 2012 | 72 | 2012 |
| Modes of human T cell leukemia virus type 1 transmission, replication and persistence A Carpentier, PY Barez, M Hamaidia, H Gazon, A De Brogniez, S Perike, ... Viruses 7 (7), 3603-3624, 2015 | 59 | 2015 |
| Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1–dependent mechanism M Hamaidia, H Gazon, C Hoyos, GB Hoffmann, R Louis, B Duysinx, ... JCI insight 4 (18), 2019 | 44 | 2019 |
| HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells N Polakowski, M Terol, K Hoang, I Nash, S Laverdure, H Gazon, ... Journal of Virology 88 (22), 13482-13494, 2014 | 36 | 2014 |
| BLV: lessons on vaccine development A Abdala, I Alvarez, H Brossel, L Calvinho, H Carignano, L Franco, ... Retrovirology 16, 1-6, 2019 | 33 | 2019 |
| HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression M Terol, H Gazon, I Lemasson, M Duc-Dodon, B Barbeau, R Césaire, ... Leukemia 31 (10), 2235-2243, 2017 | 33 | 2017 |
| Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients H Gazon, G Belrose, M Terol, JC Meniane, JM Mesnard, R Cesaire, ... Oncotarget 7 (21), 30258, 2016 | 27 | 2016 |
| Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery H Gazon, PS Chauhan, F Porquet, GB Hoffmann, R Accolla, L Willems Blood advances 4 (21), 5574-5579, 2020 | 17 | 2020 |
| How does htlv-1 undergo oncogene-dependent replication despite a strong immune response? H Gazon, P Chauhan, M Hamaidia, C Hoyos, L Li, R Safari, L Willems Frontiers in Microbiology 8, 2684, 2018 | 10 | 2018 |
| Hijacking of the AP-1 signaling pathway during development of ATL. Front Microbiol 8: 2686 H Gazon, B Barbeau, JM Mesnard, JM Peloponese Jr Epub 2018/01/31. https://doi. org/10.3389/fmicb. 2017.02686. Pubmed Pmid …, 2017 | 10 | 2017 |
| Recent advances in BLV research. Viruses 7: 6080–6088 PY Barez, A De Brogniez, A Carpentier, H Gazon, N Gillet, G Gutiérrez, ... | 7 | 2015 |
| A BDNF/TrKB autocrine loop stimulated by HBZ is involved in HTLV-1-infected cell-survival N Polakowski, M Terol, I Nash, K Hoang, H Gazon, T Wurm, R Césaire, ... Retrovirology 11, 1-1, 2014 | 3 | 2014 |
| The helicase-like transcription factor redirects the autophagic flux and restricts human T cell leukemia virus type 1 infection A Beauvois, H Gazon, PS Chauhan, M Jamakhani, JR Jacques, M Thiry, ... Proceedings of the National Academy of Sciences 120 (31), e2216127120, 2023 | 2 | 2023 |
| Effects of valproate on Tax and HBZ expression in ex vivo cultured ATL cells G Belrose, H Gazon, JC Meniane, S Olindo, JM Mesnard, JM Péloponèse, ... Retrovirology 11, 1-1, 2014 | 2 | 2014 |
| Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells F Porquet, L Weidong, K Jehasse, H Gazon, M Kondili, S Blacher, ... Molecular Therapy-Nucleic Acids 32, 857-871, 2023 | 1 | 2023 |
| Deregulation of RNAi silencing pathway by human T-cell leukemia virus type 1 bZIP factor (HBZ) H Gazon, JM Mesnard, R Césaire, JM Peloponese Retrovirology 11, 1-1, 2014 | 1 | 2014 |
| Switch-off the trouble: DMPK promoter targeting by CRISPRi as an original specific therapy in DM1 F Porquet, L Weidong, K Jehasse, H Gazon, M Kondili, S Blacher, ... 7th international congress of Myology, 2022 | | 2022 |
